Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155325 | SCV000205011 | benign | not specified | 2017-12-14 | criteria provided, single submitter | clinical testing | p.Pro3504Ala in Exon 53 of USH2A: This variant has been reported as a `likely ne utral? variant in an Usher syndrome study based on either its presence in an aff ected individual who carried two other causative variants or because it did not segregate with disease (Le Quesne Stabej 2012). It was also identified in 1/878 (0.12%) control chromosomes by the same study (Le Quesne Stabej 2012), and in 1. 1% (348/30782) of South Asian chromosomes including 8 homozygotes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; rs200372118). Th e proline (Pro) residue at position 3504 is not conserved in several species mam mals, with rat and mouse having an alanine (Ala), and computational tools (amino acid biochemical properties, SIFT, PolyPhen-2, AlignGVGD) do not suggest an imp act to the protein. In summary, this variant is not expected to have clinical si gnificance based on the conservation and computational data, and its presence in the general population. |
Eurofins Ntd Llc |
RCV000155325 | SCV000702335 | benign | not specified | 2016-10-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000911992 | SCV001057076 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000986522 | SCV001135537 | benign | Usher syndrome type 2A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000911992 | SCV001833774 | benign | not provided | 2019-03-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22135276, 28281779, 25999674) |
Ce |
RCV000911992 | SCV004125600 | benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BS1, BS2 |
Genome- |
RCV003453168 | SCV004182552 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000986522 | SCV004182554 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000986522 | SCV001459536 | benign | Usher syndrome type 2A | 2019-12-16 | no assertion criteria provided | clinical testing |